Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares traded up 0.8% on Tuesday . The company traded as high as $13.31 and last traded at $13.05. 1,265,037 shares traded hands during trading, an increase of 274% from the average session volume of 337,931 shares. The stock had previously closed at $12.95.
Silverback Therapeutics Price Performance
The stock has a market capitalization of $470.56 million, a PE ratio of -5.39 and a beta of 0.60. The business’s fifty day moving average price is $11.64 and its two-hundred day moving average price is $9.87.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What is Short Interest? How to Use It
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Transportation Stocks Investing
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
